PRODUCT
SunRecome™ is a patented Chinese herbal extract containing the spores, fruiting body and concentrated triterpenoids and polysaccharides from red reishi mushrooms (known in China as lingzhi; Latin name: Ganoderma lucidum). This product is compatible with traditional western cancer treatments, including chemotherapy and radiation therapy.

HISTORY
More than 2,100 years ago, the ancient Chinese Materia Medica hailed lingzhi as a “superior herb” because of its multitude of healing properties that produce no negative side effects. Today’s worldwide experts in Traditional Chinese Medicine (TCM) concur that lingzhi continues to reign as the most powerful, versatile and safe medicinal herb.

ADVANCES
Using modern methods to study lingzhi, Dr. Jinsheng Chen of the Shanghai Green Valley Manufacturing Company in China became the first to: 1) define lingzhi’s molecular structure; 2) isolate its triterpenoid molecule.

PATENTS
As Green Valley’s chief scientist, Dr. Chen applied his lingzhi research to the development of cancer research. This product, introduced in 1997, has been awarded three Chinese patents for: extracting and concentrating triterpenoids from lingzhi’s fruiting body; effectively breaking open lingzhi’s spores to release their immune-boosting polysaccharides; and formulating the highest quality spores, fruiting body and triterpenoids into a medicinal extract.

UNIQUENESS
1) SunRecome is the first lingzhi product to receive patent protection. 2) In China, the world’s largest producer of lingzhi, SunRecome outsells all other lingzhi products combined.

MANUFACTURING
SunRecome is manufactured in China at the Xi’an Green Valley Pharmaceutical Company, Ltd. This facility is certified to comply with international standards for quality assurance (ISO 9002) and with Good Manufacturing Practices (GMP) specified for Traditional Chinese Medicine.

CULTIVATION
The SunRecome formula requires a large amount of raw materials, specifically 1,000 pounds of lingzhi’s spores to extract just one pound of triterpenoid powder, and 20 pounds of lingzhi’s spores, fruiting body and triterpenoid powder to produce one pound of the SunRecome extract. But the natural supply of lingzhi is limited, because this rare fungus grows wild on only two or three of every 10,000 aged trees in coastal provinces of China. So in 1997, Green Valley developed the world’s first cultivation site that mimics lingzhi’s natural soil, water, sunlight, climate and growth conditions. Harvested lingzhi undergo DNA analysis at Green Valley’s Xi’an facility to identify the highest quality raw materials for use in SunRecome. 

DIRECTIONS
SunRecome is a powdered, concentrated extract. The contents of each 2-gram hermetically sealed packet must be mixed with 2 ounces of hot water to release the product’s active ingredients. After the mixture has cooled, it is consumed one hour prior to meals. Patients take two to four packets each day while undergoing chemotherapy or radiation treatments.  

MANUFACTURER
The Green Valley Holding Company, Ltd. (www.green-valley.com), based in Shanghai, China, oversees all SunRecome operations. Green Valley employs more than 4,000 people, including 600 medical and pharmaceutical experts and 500 technical personnel, located in 126 branch offices throughout 29 provinces. Green Valley has been named three times in the last five years as a top 100 private high-technology enterprise and a top 50 industrial enterprise by the Shanghai Industry Business Bureau, representing the most densely populated manufacturing area of China. Green Valley was founded in January 1997 by Mr. Song Tao Lu, president and chairman of the board.

IMPORTER
USA Golden Vision Inc., an American company, is the exclusive U.S. and Canadian importer of SunRecome. USA Golden Vision representatives have extensively interviewed 47 of Green Valley’s clinical patients, doctors, scientists and executives and have toured the company’s manufacturing facilities.  Contact us for more information.

The United States FDA has not reviewed this herbal product or these statements.